- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04124874
Prevalence and Impact on Quality of Life of Lower Urinary Tract Symptoms (LUTS) in Night Workers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The first large population-based study to evaluate lower urinary tract symptoms (LUTS) and their impact on quality of life in night workers. The study objective is to assess the prevalence and bother of LUTS in the population of night workers.
This study will be conducted as a questionnaire survey with assessment of LUTS using a standardized protocol based on definitions by the International Continence Society (ICS). The International Prostate Symptom Score (IPSS), the Overactive Bladder- Validated 8-question Screener (OAB-V8), the Patient Health Questionnaire-9 (PHQ-9), the Athen Insomnia Scale, the Work Productivity and Activity Impairment Questionnaire (WPAI), the 12-Item Short Form Health Survey (SF-12) questionnaires will be included. Participants will be also asked to rate how often they experienced individual LUTS and the degree of associated bother.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Krakow, Poland
- Department of Urology Jagiellonian University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Night workers defined as any workers, who, during night time, work at least three hours of their daily working time as a normal course or who work at night at least 1/4 of their working time during the accounting period (definition by the Polish Labour Code).
Exclusion Criteria:
Non night workers Urinary tract infection in the past 4 weeks
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of LUTS
Time Frame: Through study completion, an average of 3 months
|
The prevalence of LUTS will be assessed using definitions of the International Continence Society (descriptive statistics).
|
Through study completion, an average of 3 months
|
Symptom bother of LUTS
Time Frame: Through study completion, an average of 3 months
|
The degree of associated bother will be assessed using Likert scale (Likert scale: not at all [score 0], a little bit [score 1], somewhat [score 2], quite a bit [score 3], a great deal [score 4], or a very great deal [score 5]).
|
Through study completion, an average of 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of specific lower urinary tract symptoms
Time Frame: Through study completion, an average of 3 months
|
The prevalence of specific lower urinary tract symptoms will be assessed using a standardised protocol based on the definitions provided by the International Continence Society (i.e.
storage symptoms, voiding symptoms and post-micturition symptoms).
|
Through study completion, an average of 3 months
|
Symptom bother of specific lower urinary tract symptoms
Time Frame: Through study completion, an average of 3 months
|
The degree of associated bother of specific lower urinary tract symptoms will be assessed using Likert scale (Likert scale: not at all [score 0], a little bit [score 1], somewhat [score 2], quite a bit [score 3], a great deal [score 4], or a very great deal [score 5]).
|
Through study completion, an average of 3 months
|
Prevalence of OAB
Time Frame: Through study completion, an average of 3 months
|
The prevalence of OAB will be assessed with the Overactive Bladder-Validated 8-question Screener (OAB- V8) questionnaire.
|
Through study completion, an average of 3 months
|
Prevalence of depressive symptoms
Time Frame: Through study completion, an average of 3 months
|
The prevalence of depressive symptoms will be assessed with the PHQ-9 (Patient Health Questionnaire-9).
|
Through study completion, an average of 3 months
|
Sleep quality
Time Frame: Through study completion, an average of 3 months
|
The sleep quality will be assessed with the Athen Insomnia Scale questionnaire.
|
Through study completion, an average of 3 months
|
Work productivity
Time Frame: Through study completion, an average of 3 months
|
The work productivity will be assessed with the Work Productivity and Activity Impairment Questionnaire (WPAI).
|
Through study completion, an average of 3 months
|
General quality of life
Time Frame: Through study completion, an average of 3 months
|
The general quality of life will be assessed with the 12-Item Short Form Health Survey (SF-12).
|
Through study completion, an average of 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1072.6120.200.2019
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on To Evaluate Lower Urinary Tract Symptoms (LUTS) and Their Impact on Quality of Life in Night Workers
-
Jagiellonian UniversityPiotr ChlostaCompletedTo Evaluate Lower Urinary Tract Symptoms (LUTS) in PolandPoland
-
Ataturk UniversityCompletedTo Evaluate the Effect of Exercise With Virtual Glasses on Pain, Activities of Daily Living and Quality of LifeTurkey
-
Bursa Yüksek İhtisas Education and Research HospitalCompletedThe Aim of This Research is to Investigate the Effect of Prolotherapy on Quality of Life and Painkiller Use in Patients With Chronic Knee PainTurkey
-
University Hospital, GhentCompletedLower Urinary Tract SymptomsBelgium
-
University Hospital of SplitEnrolling by invitationQuality of Life | Pain | Lower Urinary Tract Symptoms | Voiding DisordersCroatia
-
Esin Merve Erol KoçCompletedQuality of Life | Urinary Incontinence | Anxiety in Pregnancy (Disorder)Turkey
-
Saglik Bilimleri UniversitesiCompletedQuality of Life | Lower Urinary Tract Symptoms | Urinary IncontinenceTurkey
-
National Taiwan University HospitalCompleted
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveCzech Republic
Clinical Trials on There will be no intervention
-
Jagiellonian UniversityPiotr ChlostaCompletedTo Evaluate Lower Urinary Tract Symptoms (LUTS) in PolandPoland
-
Assuta Medical CenterUnknown
-
Imperial College LondonCompleted
-
Kuwait UniversityCompleted
-
Afyonkarahisar Health Sciences UniversityCompletedTask Performance and AnalysisTurkey
-
Centre Hospitalier Universitaire VaudoisThe Novartis FoundationRecruiting
-
University of FreiburgCompletedCAR T-Cell-Related Encephalopathy Syndrome | ICANS, Grade UnspecifiedGermany
-
Lund UniversityRecruitingFemale | Sport Injury | Female Athlete Triad | Sports Accident | Ice-Skates AccidentSweden
-
Gazi UniversityRecruiting
-
Cambridge University Hospitals NHS Foundation TrustNot yet recruitingCystic Fibrosis in Children